Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Linda S, Lindström"'
Autor:
Josefine Sandström, Jens Bomanson, Gizeh Pérez-Tenorio, Carolin Jönsson, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindström, Olle Stål
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract GATA binding protein 3 (GATA3) is essential for normal development of the mammary gland and associated with ER-positive breast cancer. Loss of GATA3 has been associated with epithelial-mesenchymal transition (EMT) in experimental studies. We
Externí odkaz:
https://doaj.org/article/5489900ba9c54810a4ba6d86094baf2b
Autor:
Miguel Castresana-Aguirre, Annelie Johansson, Alexios Matikas, Theodoros Foukakis, Linda S. Lindström, Nicholas P. Tobin
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background The clinical utility of gene signatures in older breast cancer patients remains unclear. We aimed to determine signature prognostic capacity in this patient subgroup. Methods Research versions of the genomic grade index (GGI), 70-
Externí odkaz:
https://doaj.org/article/7787a17cbd274b328d037a1979a3c874
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-10 (2022)
Abstract Genomic alterations resulting in loss of control over the cell cycle is a fundamental hallmark of human malignancies. Whilst pan-cancer studies have broadly assessed tumour genomics and their impact on oncogenic pathways, analyses taking the
Externí odkaz:
https://doaj.org/article/9751e728fcc047beaf2952563a1b6249
Autor:
Sanne Løkkegaard, Daniel Elias, Carla L. Alves, Martin V. Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F. Gjerstorff, Lene E. Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S. Lindström, Laura J. Esserman, Anne E. Lykkesfeldt, Jens S. Andersen, Rikke Leth-Larsen, Henrik J. Ditzel
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-15 (2021)
Abstract Resistance to endocrine therapy in estrogen receptor-positive (ER+) breast cancer is a major clinical problem with poorly understood mechanisms. There is an unmet need for prognostic and predictive biomarkers to allow appropriate therapeutic
Externí odkaz:
https://doaj.org/article/c7b5ad6a5a674cfcb8ece9f12b5c68d6
Autor:
Annelie, Johansson, Huma, Dar, Laura J, van 't Veer, Nicholas P, Tobin, Gizeh, Perez-Tenorio, Anna, Nordenskjöld, Ulla, Johansson, Johan, Hartman, Lambert, Skoog, Christina, Yau, Christopher C, Benz, Laura J, Esserman, Olle, Stål, Bo, Nordenskjöld, Tommy, Fornander, Linda S, Lindström
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(35)
To assess the long-term (20-year) endocrine therapy benefit in premenopausal patients with breast cancer.Secondary analysis of the Stockholm trial (STO-5, 1990-1997) randomly assigning 924 premenopausal patients to 2 years of goserelin (3.6 mg subcut
Autor:
Arian Lundberg, Linda S. Lindström, Jingmei Li, J. Chuck Harrell, Eva Darai-Ramqvist, Emmanouil G. Sifakis, Theodoros Foukakis, Charles M. Perou, Kamila Czene, Jonas Bergh, Nicholas P. Tobin
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-10 (2019)
Abstract Background Use of cyclin D1 (CCND1) gene amplification as a breast cancer biomarker has been hampered by conflicting assessments of the relationship between cyclin D1 protein levels and patient survival. Here, we aimed to clarify its prognos
Externí odkaz:
https://doaj.org/article/8be3793f16a749efa5f0ae8a141a5f09
Autor:
Oscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, Anna Nordenskjöld, Christina Yau, Christopher C. Benz, Laura J. Esserman, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Annelie Johansson, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P3-05
Background: Women with estrogen receptor (ER)-positive disease have a long-term risk of distant recurrence. The poor survival of premenopausal women diagnosed with breast cancer combined with the otherwise long life expectancy makes it especially imp
Autor:
Xinhe Mao, Wei He, Mikael Eriksson, Linda S Lindström, Natalie Holowko, Svetlana Bajalica-Lagercrantz, Mattias Hammarström, Felix Grassmann, Keith Humphreys, Douglas Easton, Per Hall, Kamila Czene
Publikováno v:
JNCI: Journal of the National Cancer Institute.
Background Risk assessment is important for breast cancer prevention and early detection. We aimed to examine whether common risk factors, mammographic features and breast cancer risk prediction scores of a woman were associated with breast cancer ri
Autor:
Jonas Bergh, Christer Betsholtz, Göran Landberg, Arne Östman, Guillem Genové, Liqun He, Theodoros Foukakis, Linda S. Lindström, Kristian Wennmalm, Nicholas P. Tobin
Multivariable analysis of prognostic markers in endocrine-treated patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ac13c1f251af9a2e6b4e70846d42c99
https://doi.org/10.1158/1078-0432.22459767
https://doi.org/10.1158/1078-0432.22459767
Autor:
Thomas Hatschek, Jonas Bergh, Charles M. Perou, Kamila Czene, Mårten Fernö, Martin Malmberg, Niklas Loman, Barbro K. Linderholm, Zakaria Einbeigi, Lena Carlsson, Theodoros Foukakis, J. Chuck Harrell, Linda S. Lindström, Arian Lundberg, Nicholas P. Tobin
Supplementary Figure 1 CONSORT diagram, TEX cohort Supplementary Figure 2 Long term post-relapse BCSS for gene expression signatures Supplementary Figure 3 Short term post-relapse BCSS for gene expression signatures Supplementary Figure 4 Long and sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88108492bf21021dcf5a3a3dfdc76c5f
https://doi.org/10.1158/1078-0432.22467323.v1
https://doi.org/10.1158/1078-0432.22467323.v1